Accidental Formation of Eutectics during Crystal Engineering of Lamotrigine with Solubility Advantage and Drug Release Efficiency

IF 0.4 Q4 PHARMACOLOGY & PHARMACY
Deepak Kulkarni
{"title":"Accidental Formation of Eutectics during Crystal Engineering of Lamotrigine with Solubility Advantage and Drug Release Efficiency","authors":"Deepak Kulkarni","doi":"10.22377/AJP.V15I1.3960","DOIUrl":null,"url":null,"abstract":"Objective: Lamotrigine (LMG) is the Biopharmaceutical Classification System Class-II drug with hurdle in drug release and dissolution efficiency due to poor water solubility. The present investigation was aimed to improve the solubility and dissolution of LMG by crystal engineering by formation of cocrystals but which accidently turn toward eutectics formation. Methods: LMG was subjected to neat grinding with different Cocrystal Formers (CCF) to develop multicomponent crystalline system. The prepared multicomponent system was analyzed by Differential Scanning Calorimetry, Raman spectroscopy, and Powder X-ray Diffraction reveals the formation of multicomponent system. Improved dissolution was interpreted by comparative drug release study of tablet formulation of unprocessed drug and eutectics. Results: There was unplanned formation of eutectics of LMGAscorbic acid (LMG-AA) that was observed with improved drug solubility. LMG-AA eutectics showed enhanced solubility (651.61 ± 1.02 μg/ml) in comparison with pure drug (161.46 ± 0.86 μg/ml) and all remaining multicomponent systems formed with other CCF’s. The LMG-AA eutectics showed comparatively better drug release than pure LMG tablet. LMG eutectics also showed significant improvement in flow properties and compressibility as compared to pure drug. Conclusion: Multicomponent LMG-AA eutectics although formed in unplanned way they effectively enhances the solubility of LMG serving the main purpose of the research work. It can be utilized efficiently for drug delivery due to its improved dissolution and better drug release.","PeriodicalId":8489,"journal":{"name":"Asian Journal of Pharmaceutics","volume":" ","pages":""},"PeriodicalIF":0.4000,"publicationDate":"2021-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Pharmaceutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22377/AJP.V15I1.3960","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 7

Abstract

Objective: Lamotrigine (LMG) is the Biopharmaceutical Classification System Class-II drug with hurdle in drug release and dissolution efficiency due to poor water solubility. The present investigation was aimed to improve the solubility and dissolution of LMG by crystal engineering by formation of cocrystals but which accidently turn toward eutectics formation. Methods: LMG was subjected to neat grinding with different Cocrystal Formers (CCF) to develop multicomponent crystalline system. The prepared multicomponent system was analyzed by Differential Scanning Calorimetry, Raman spectroscopy, and Powder X-ray Diffraction reveals the formation of multicomponent system. Improved dissolution was interpreted by comparative drug release study of tablet formulation of unprocessed drug and eutectics. Results: There was unplanned formation of eutectics of LMGAscorbic acid (LMG-AA) that was observed with improved drug solubility. LMG-AA eutectics showed enhanced solubility (651.61 ± 1.02 μg/ml) in comparison with pure drug (161.46 ± 0.86 μg/ml) and all remaining multicomponent systems formed with other CCF’s. The LMG-AA eutectics showed comparatively better drug release than pure LMG tablet. LMG eutectics also showed significant improvement in flow properties and compressibility as compared to pure drug. Conclusion: Multicomponent LMG-AA eutectics although formed in unplanned way they effectively enhances the solubility of LMG serving the main purpose of the research work. It can be utilized efficiently for drug delivery due to its improved dissolution and better drug release.
拉莫三嗪晶体工程过程中偶然形成的共晶具有溶解度优势和药物释放效率
目的:拉莫三嗪(LMG)是生物制药分类系统II类药物,由于水溶性差,其释放和溶出效率存在障碍。本研究旨在通过晶体工程,通过形成共晶,但意外地转向形成共晶来提高LMG的溶解度和溶解性。方法:用不同的共晶剂(CCF)对LMG进行纯研磨,形成多组分结晶体系。通过差示扫描量热法、拉曼光谱和粉末X射线衍射对制备的多组分体系进行了分析,揭示了多组分系统的形成。通过对未加工药物和共晶药物片剂配方的药物释放度比较研究,解释了溶出度的改善。结果:LMGA抗坏血酸(LMG-AA)存在非计划的共晶形成,药物溶解度提高。与纯药物(161.46±0.86μg/ml)和其他CCF形成的所有剩余多组分体系相比,LMG-AA共晶显示出增强的溶解度(651.61±1.02μg/ml)。LMG-AA共熔物显示出比纯LMG片剂相对更好的药物释放。与纯药物相比,LMG共晶在流动特性和压缩性方面也表现出显著的改善。结论:多组分LMG-AA共晶虽然是以非计划的方式形成的,但它们有效地提高了LMG的溶解度,这是研究工作的主要目的。由于其改善的溶解性和更好的药物释放,它可以有效地用于药物递送。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Asian Journal of  Pharmaceutics
Asian Journal of Pharmaceutics PHARMACOLOGY & PHARMACY-
自引率
0.00%
发文量
47
期刊介绍: Character of the publications: -Pharmaceutics and Pharmaceutical Technology -Formulation Design and Development -Drug Discovery and Development Interface -Manufacturing Science and Engineering -Pharmacokinetics, Pharmacodynamics, and Drug Metabolism -Clinical Pharmacology, General Medicine and Translational Research -Physical Pharmacy and Biopharmaceutics -Novel Drug delivery system -Biotechnology & Microbiological evaluations -Regulatory Sciences
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信